Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S., Europe, and India
Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide's fully diluted share capital (excluding therefrom any treasury shares) at CHF 44.31 per share, representing an equity value of approximately CHF 1.46 billion....
Aduna and Bridge Alliance partner to accelerate access to network APIs
STOCKHOLM, March 2, 2025 /PRNewswire/ -- Aduna, a landmark venture between some of the world's leading telecom operators and Ericsson, is set to partner with Bridge Alliance to accelerate the adoption of CAMARA-based network Application Programming...